B cells are enriched in IPF lung tissues (13), and circulating B cell-activating factors and B cell chemotactic mediator CXCL13 are highly expressed in IPF patients, suggesting a pivotal role for B cells in IPF progression. The gene discussed is CXCL13; the disease is idiopathic interstitial pneumonia.